Atlas Trials

Combination Study for High Risk Multiple Myeloma Patients

Clinical trial NCT03104270 · TERMINATED

Trial details

NCT number
NCT03104270
Sponsor
Oncotherapeutics
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2017-03-13
Primary completion
2019-10-25
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.